January 31, 2022 - 10:00 ET
RENO, NV, January 31, 2022 /CTFOInTheNews /
CTFO, Inc. (CTFO) announces the introduction and expansion of their most successful product to date with the launch of the much anticipated:
• 10xPURE™-GOLD SUPER 500 enriched with 150 mg of CBDa
• 10xPURE™-GOLD SUPER 1500 enriched with 450 mg of CBDa
CTFO made history in July 2019 bringing a first-of-its-kind product to the public, 10xPURE™ SUPER 1000 enriched with 300 mg of naturally stabilized CBDa and 700 mg of cannabinoids. All CTFO products are backed by the CTFOPROMISE, a 60-day no questions asked money-back guarantee.
CTFO has focused on cannabinoid acid molecules, such as CBDa, that have long been said to be 1000 times more potent than CBD for select therapeutic benefits.
Global CBD market size is projected at $39.99 billion by 2027, a 46.4% compound annual growth rate, by FortuneBusinessinsights.com, a research company. CTFO believes a large percentage of that business could be CTFO 10xPURE™ cannabinoid acids, such as CBDa, formulated individually, together, or in combination with CBD.
CTFO has diligently documented cannabinoid-acid stability with a current 15-month milestone supported by documented lab results with no meaningful potency degradation of the acids such as CBDa.
"David D'Arcangelo, overseeing the science and product development, wanted to leverage our 10xPURE™ technology to give millions of consumers access to the primary molecules in the hemp plant, such as CBDa & CBGa. CBD is a secondary molecule and could be most potent when combined with stabilized cannabinoid acids such as CBDa" — Stuart Finger, CTFO CEO
"David D'Arcangelo, overseeing the science and product development, wanted to leverage our 10xPURE™ technology to give millions of consumers access to the primary molecules in the hemp plant, such as CBDa & CBGa. CBD is a secondary molecule and could be most potent when combined with stabilized cannabinoid acids such as CBDa," said Stuart Finger, CTFO CEO.
As an example of CTFO's commitment to be a first-to-market leader in Jan. 2021, CTFO launched another industry first, BLISS - extra-strength happy containing 200mg of CBGa, followed by CTFO 10xPURE™ Gourmet Black Coffee and Vanilla Latte, both enriched with CBDa.
"Today, CTFO made a powerful statement. The launch of some of the most potent and bioavailable solutions anywhere in the world and priced at seemingly impossible low prices." said Kevin Fournier, President, CTFO.
CTFO, founded in 2015, is a US-based health & wellness company doing business in the U.S.A., Canada and fifteen European countries. CTFO acquires, discovers, formulates and distributes product solutions direct to consumers through its independent associates network sales & marketing teams. CTFO's vision — provide tools to empower people in business, health and serving others; demonstrating the Good News with quality, integrity and generosity.
For more information, visit myctfo.com.
Contact: David D'Arcangelo,
Global Marketing Director